|
If you are in the process of raising capital for your company
or preparing for the public market, we strongly encourage you to apply to present at the
SoCalBio Investor Conference.
This conference is appropriate for device,
IVD and biotech/biopharma
companies that meet the following criteria:
- Company is planning
to raise capital from institutional or individual sources, find partners, and/or go public.
- Company must pass a rigorous screening process to be invited to present.
- Company must undergo a rigorous mentoring process with the help of professional service
providers who work with emerging technology companies. The process will assist you in developing and
fine-tuning company presentation to ensure that the presentations are responsive to the needs and
expectations of the investor audience and to help you make the biggest impact.
To Apply:
Simply e-mail an executive summary to scbc@socalbio.org
What Happens
Next?
When we get your
exec summary, you will be scheduled to make a presentation to
company screening and selection committee.
Who
participates on the Company Screening and Selection Committee?
- Allan Wolfe, UV Partners <awolfe@uven.com>
- Michael Wise, Perkins Coie <MWise@perkinscoie.com>
- Ramsey Hanna, Reed Smith <rhanna@reedsmith.com>
- Julia Jun, Ernst & Young <julia.jun@ey.com>
- Bruce Blomstrom, Pasadena Angels <bblomstrom@aol.com>
- Dennis Atkinson, USC <djatkins@usc.edu>
- Jon Lasch, AMI-USC <lasch@usc.edu>
- Jerry Knotts, JE Knotts & Associates <jeknotts@roadrunner.com>
- Mark Wittman, UCI <mwittman3@adelphia.net>
- Tom Lobl, Neurosystec" <tlobl@neurosystec.com>
- Darin Chen, Hillcrest Venture Partners
darin@hillcrestvp.com
- Dave Skibinski, Quantum Methods <dave@quantummethod.com>
- Monica Welling, Strategic Links <MWelling@strategiclinks3.com>
- Brian Clark, City of Hope <BClark@coh.org>
- Robert Funsten, Bingham McCutchen <rob.funsten@bingham.com>
- Sharon Stevenson, Okapi Ventures <stevenson@okapivc.com>
- Ken Ohriner, Perkins Coie <kohriner@perkinscoie.com>
|
